|
China Pediatric Pharmaceuticals, Inc. (CPDU) |
|
|
|
CPDU's Revenue Growth by Quarter and Year
China Pediatric Pharmaceuticals,'s Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
CPDU Revenue (in millions $) |
FY 2014 |
FY 2013 |
FY 2012 |
FY 2011 |
IV Quarter |
December |
-
|
1.12
|
1.21
|
0.00
|
III Quarter |
September |
-
|
0.79
|
1.96
|
0.00
|
II Quarter |
June |
-
|
0.94
|
6.16
|
0.00
|
I Quarter |
March |
1.58
|
0.88
|
4.83
|
0.00
|
FY |
|
1.58
|
3.73
|
14.16
|
0.00
|
CPDU Revenue first quarter 2014 Y/Y Growth Comment |
China Pediatric Pharmaceuticals, Inc. achieved in the first quarter 2014, above Company average Revenue rise of 79.68% year on year, to $ 1.58 millions.
Looking into first quarter 2014 results within Healthcare Facilities industry 2 other companies have achieved higher Revenue growth. While China Pediatric Pharmaceuticals, Inc.' s Revenue jump of 79.68% ranks overall at the positon no. 234 in the first quarter 2014.
|
CPDU Revenue ( Y/Y Growth %) |
2014
|
2013 |
2012 |
2011 |
IV Quarter |
December |
- |
-7.44 % |
- |
- |
III Quarter |
September |
- |
-59.69 % |
- |
- |
II Quarter |
June |
- |
-84.74 % |
- |
- |
I Quarter |
March |
79.68 % |
-81.78 % |
- |
- |
FY |
|
- |
-73.66 % |
- |
- |
CPDU Revenue (Quarter on Quarter Growth %) |
2014
|
2013 |
2012 |
2011 |
IV Quarter |
December |
- |
41.77 % |
-38.27 % |
- |
III Quarter |
September |
- |
-15.96 % |
-68.18 % |
- |
II Quarter |
June |
- |
6.82 % |
27.54 % |
- |
I Quarter |
March |
41.18 % |
-27.27 % |
- |
- |
FY (Year on Year) |
|
- |
-73.66 % |
- |
- |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
79.17 % |
-30.95 % |
-84.82 % |
(Mar 31 2014) |
|
(Jun 30 2013) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
79.17 % |
-30.95 % |
-84.82 % |
(Mar 31 2014) |
|
(Jun 30 2013) |
|
Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014 |
China Pediatric Pharmaceuticals,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
42.83 % |
-4.05 % |
-68.18 % |
(Dec 31 2013) |
|
|
CPDU's I. Quarter Q/Q Revenue Comment |
China Pediatric Pharmaceuticals, Inc. achieved in the I. Quarter 2014 above company average sequential Revenue jump of 41.18%, to $ 1.58 millions, from $1.12 millions in the fourth quarter.
Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While China Pediatric Pharmaceuticals,'s Revenue growth quarter on quarter, overall rank is 279. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
42.83 % |
-4.05 % |
-68.18 % |
(Dec 31 2013) |
|
|
CPDU's I. Quarter Q/Q Revenue Comment |
China Pediatric Pharmaceuticals, Inc. achieved in the I. Quarter 2014 above company average sequential Revenue jump of 41.18%, to $ 1.58 millions, from $1.12 millions in the fourth quarter.
Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While China Pediatric Pharmaceuticals,'s Revenue growth quarter on quarter, overall rank is 279. |
|
China Pediatric Pharmaceuticals,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Mar 31 2014) |
12 Months Ending (Dec 31 2013) |
12 Months Ending (Sep 30 2013) |
12 Months Ending (Jun 30 2013) |
12 Months Ending (Mar 31 2013) |
Cumulative Revenue 12 Months Ending |
$ 4.42 |
$ 3.73 |
$ 3.82 |
$ 4.99 |
$ 10.22 |
Y / Y Revenue Growth (TTM) |
-56.69 % |
-73.7 % |
- |
- |
- |
Year on Year Revenue Growth Overall
Ranking |
# 3026 |
# 3028 |
# 0 |
# 0 |
# 0 |
Seqeuential Revenue Change (TTM) |
18.75 % |
-2.36 % |
-23.53 % |
-51.15 % |
-27.89 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 183 |
# 178 |
# 0 |
# 0 |
# 2526 |
Cumulative Revenue growth
Comment |
China Pediatric Pharmaceuticals, showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2013. If the fiscal year would end in Mar 31 2014, China Pediatric Pharmaceuticals,'s annual Revenue drop would be -56.69% year on year to $4 millions.
In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3026, from total ranking in previous quarter at 3028. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
18.75 % |
8.19 % |
-2.36 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
-56.69 % |
-65.19 % |
-73.7 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 35 |
S&P 500 |
# 183 |
|
Cumulative Revenue growth
Comment |
China Pediatric Pharmaceuticals, showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2013. If the fiscal year would end in Mar 31 2014, China Pediatric Pharmaceuticals,'s annual Revenue drop would be -56.69% year on year to $4 millions.
In the Healthcare sector 322 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 3026, from total ranking in previous quarter at 3028. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
18.75 % |
8.19 % |
-2.36 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
-56.69 % |
-65.19 % |
-73.7 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 3 |
Sector |
# 35 |
S&P 500 |
# 183 |
|